IndustrialsNasdaqsmall
Institutional-grade research for retail investors
SEC EDGAR: CIK 45919HHS stock profile & AI dashboard →

13F Pro Quality Score

24.1/100

Rank #2,710 of 2,962 stocks

View Industrials peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

8.9/100

Profitability

25.9/100

Balance Sheet

20.9/100

Earnings Quality

22.5/100

Free Cash Flow

25.0/100

Institutional Flow

22.8/100

Revenue Scale

20.6/100

Dilution Risk

86.5/100
Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

HHS Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for HARTE HANKS INC (HHS), a Industrials sector company. 13F Pro's AI-powered ranking engine scores HHS at 24.1/100 on a 32-signal composite quality model, placing it at rank #2,710 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (8.9) and revenue scale (20.6), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), HARTE HANKS INC reports quarterly revenue of $38.0M, net income of $-5.0M, free cash flow of $-2.1M. Top institutional holders of HHS by reported 13-F value include BLAIR WILLIAM, WESTERLY CAPITAL MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. HHS trades on the Nasdaq exchange and files with the SEC under CIK 45919. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HHS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for HARTE HANKS INC directly from SEC EDGAR. HARTE HANKS INC's 13F Pro composite quality score has ranged between 19 and 55 since 2022, currently 24.1 — a declining long-term trajectory across 62 quarterly and live scoring snapshots.

Fun facts about HARTE HANKS INC

Quirks, history, and lore behind HHS — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    A B2B services company · small-cap · listed on NYSE American · headquartered in Texas.
  • 2
    The Numbers
    Annual revenue in the range of a few hundred million dollars, with a workforce that has shrunk considerably over the decades as the industry shifted digital.
  • 3
    The History
    Founded in the 1960s, it built its name in direct mail and database marketing back when a stuffed mailbox was the cutting edge of customer outreach.
  • 4
    The Secret
    It pivoted hard into customer experience management — think contact centers, fulfillment, and data analytics — trying to stay relevant as physical mail became a punchline.
  • 5
    The Lore
    For decades it ran one of the largest direct-mail databases in the U.S., helping brands reach millions of households with the kind of targeted data that Facebook would later make look quaint.
  • 6
    The Giveaway
    Its name pairs a Texas newspaper dynasty surname with a classic marketing services word — a legacy combo that screams old-school direct response advertising.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q2 2026

$38.0M

Net Income

Q2 2026

$-5.0M

Free Cash Flow

Q2 2026

$-2.1M

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

-13.9% YoY
$159.6MFY 2025
FY22 $206.3MFY23 $191.5MFY24 $185.2MFY25 $159.6M

Net Income

+97.3% YoY
$-811.0KFY 2025
FY22 $36.8MFY23 $-1.6MFY24 $-30.3MFY25 $-811.0K

Operating Income

-81.6% YoY
$386.0KFY 2025
FY22 $15.1MFY23 $3.4MFY24 $2.1MFY25 $386.0K

EPS (Diluted)

+97.3% YoY
$-0.11FY 2025
FY22 $4.75FY23 $-0.21FY24 $-4.15FY25 $-0.11

Total Assets

-9.8% YoY
$91.8MFY 2025
FY22 $120.0MFY23 $122.8MFY24 $101.8MFY25 $91.8M

Total Debt

$0.00FY 2025
FY22 $0.00FY23 FY24 FY25 $0.00

Op. Cash Flow

+41.9% YoY
$-1.7MFY 2025
FY22 $28.8MFY23 $10.5MFY24 $-3.0MFY25 $-1.7M

Free Cash Flow

+33.3% YoY
$-4.5MFY 2025
FY22 $23.0MFY23 $7.7MFY24 $-6.7MFY25 $-4.5M

Get alerted when HHS's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for HARTE HANKS INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Companies Similar to HHS

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

JOB

GEE Group Inc.

35
AI score
Very similar · 1 shared holders
AP

AMPCO PITTSBURGH CORP

30
AI score
Very similar · 1 shared holders
AWX

AVALON HOLDINGS CORP

39
AI score
Very similar · 1 shared holders
SCOR

COMSCORE, INC.

35
AI score
Similar quality profile · 1 shared holders
KELYA

KELLY SERVICES INC

34
AI score
Similar quality profile · 2 shared holders
SGRP

SPAR Group, Inc.

17
AI score
Similar quality profile
STLA

Stellantis N.V.

29
AI score
Similar quality profile
MTRX

MATRIX SERVICE CO

48
AI score
Similar quality profile · 1 shared holders

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

Put HHS on your watchlist

Track score changes the day HARTE HANKS INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is HHS a good stock to buy?

13F Pro's AI-powered analysis of HARTE HANKS INC (HHS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Industrials sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for HHS are available on the HHS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. HHS is classified as a small company.

Which hedge funds own HHS?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling HHS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of HARTE HANKS INC's investment landscape.